PD-RX Pharmaceuticals (PDRX) Ratios
2 Followers
PD-RX Pharmaceuticals Ratios
PDRX's free cash flow for Q? was ―. For the fiscal year, PDRX's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.34 | 4.97 | 6.71 | 6.44 | 4.14 |
| Quick Ratio | 5.27 | 3.99 | 5.75 | 5.45 | 3.04 |
| Cash Ratio | 3.68 | 2.37 | 4.03 | 2.94 | 1.20 |
| Solvency Ratio | -0.06 | -0.25 | 0.02 | 1.70 | 0.81 |
| Operating Cash Flow Ratio | 0.46 | -0.59 | 1.05 | 1.74 | -0.19 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 8.88M | $ 8.98M | $ 9.70M | $ 10.12M | $ 7.57M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.17 | 1.23 | 1.15 | 1.16 | 1.29 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 18.80 | 9.65 | -556.43 | -1.32 | -1.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.61% | 29.68% | 31.56% | 38.52% | 32.20% |
| EBIT Margin | -2.60% | -3.76% | -0.60% | 13.95% | 8.49% |
| EBITDA Margin | -1.79% | -2.96% | 0.06% | 14.39% | 9.02% |
| Operating Profit Margin | -2.60% | -5.02% | -0.90% | 13.95% | 4.06% |
| Pretax Profit Margin | -1.52% | -3.76% | -0.60% | 14.11% | 8.49% |
| Net Profit Margin | -1.40% | -3.98% | -0.46% | 10.57% | 8.59% |
| Continuous Operations Profit Margin | -1.40% | -3.98% | -0.46% | 10.57% | 8.59% |
| Net Income Per EBT | 92.39% | 105.78% | 77.35% | 74.86% | 101.18% |
| EBT Per EBIT | 58.39% | 74.82% | 66.56% | 101.21% | 209.33% |
| Return on Assets (ROA) | -2.15% | -5.86% | -0.76% | 22.95% | 17.01% |
| Return on Equity (ROE) | -2.51% | -7.18% | -0.87% | 26.73% | 21.88% |
| Return on Capital Employed (ROCE) | -4.63% | -8.99% | -1.69% | 35.24% | 10.31% |
| Return on Invested Capital (ROIC) | -4.28% | -8.99% | -1.31% | 26.38% | 10.31% |
| Return on Tangible Assets | -2.15% | -5.86% | -0.76% | 22.95% | 17.01% |
| Earnings Yield | -6.92% | -13.09% | -1.00% | 56.34% | 37.98% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.77 | 5.96 | 8.95 | 6.44 | 5.56 |
| Payables Turnover | 15.57 | 8.77 | 14.66 | 15.24 | 8.89 |
| Inventory Turnover | 7.20 | 5.97 | 8.88 | 9.61 | 5.52 |
| Fixed Asset Turnover | 14.34 | 13.19 | 13.96 | 23.19 | 25.98 |
| Asset Turnover | 1.53 | 1.47 | 1.64 | 2.17 | 1.98 |
| Working Capital Turnover Ratio | 2.04 | 2.02 | 2.15 | 3.24 | 3.04 |
| Cash Conversion Cycle | 68.89 | 80.79 | 57.02 | 70.66 | 90.74 |
| Days of Sales Outstanding | 41.63 | 61.23 | 40.79 | 56.64 | 65.69 |
| Days of Inventory Outstanding | 50.70 | 61.17 | 41.13 | 37.97 | 66.09 |
| Days of Payables Outstanding | 23.44 | 41.61 | 24.89 | 23.96 | 41.04 |
| Operating Cycle | 92.34 | 122.40 | 81.91 | 94.62 | 131.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.50 | -0.82 | 1.09 | 1.95 | -0.27 |
| Free Cash Flow Per Share | 0.49 | -0.87 | 0.83 | 1.62 | -0.33 |
| Dividend Paid and CapEx Coverage Ratio | 313.28 | -17.33 | 4.19 | 5.88 | -4.32 |
| Capital Expenditure Coverage Ratio | 313.28 | -17.33 | 4.19 | 5.88 | -4.32 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.04 | -0.07 | 0.08 | 0.11 | -0.02 |
| Free Cash Flow Yield | 20.48% | -24.82% | 13.89% | 49.86% | -11.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.18 | -7.64 | -99.98 | 1.77 | 2.63 |
| Price-to-Sales (P/S) Ratio | 0.20 | 0.30 | 0.46 | 0.19 | 0.23 |
| Price-to-Book (P/B) Ratio | 0.36 | 0.55 | 0.87 | 0.47 | 0.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.88 | -4.03 | 7.20 | 2.01 | -8.52 |
| Price-to-Operating Cash Flow Ratio | 4.87 | -4.26 | 5.48 | 1.66 | -10.49 |
| Price-to-Earnings Growth (PEG) Ratio | 0.22 | -0.01 | 0.97 | 0.03 | -0.00 |
| Enterprise Value Multiple | 7.45 | -0.63 | 241.88 | -0.02 | 1.02 |
| Enterprise Value | -2.44M | 353.01K | 2.97M | -87.11K | 1.98M |
| EV to EBITDA | 7.45 | -0.63 | 241.88 | -0.02 | 1.02 |
| EV to Sales | -0.13 | 0.02 | 0.14 | -0.00 | 0.09 |
| EV to Free Cash Flow | -3.20 | -0.25 | 2.18 | -0.03 | -3.46 |
| EV to Operating Cash Flow | -3.19 | -0.26 | 1.66 | -0.03 | -4.26 |
| Tangible Book Value Per Share | 6.63 | 6.38 | 6.89 | 6.86 | 4.95 |
| Shareholders’ Equity Per Share | 6.63 | 6.38 | 6.89 | 6.85 | 4.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | -0.06 | 0.23 | 0.25 | -0.01 |
| Revenue Per Share | 11.88 | 11.52 | 13.02 | 17.33 | 12.60 |
| Net Income Per Share | -0.17 | -0.46 | -0.06 | 1.83 | 1.08 |
| Tax Burden | 0.92 | 1.06 | 0.77 | 0.75 | 1.01 |
| Interest Burden | 0.58 | 1.00 | 1.00 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.32 | 0.34 | 0.32 | 0.24 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -2.97 | 1.79 | -18.24 | 1.07 | -0.25 |
Currency in USD
